Study defines clinical trials likely to exclude patients with brain metastases
9/10/2015
Non-small cell lung cancer frequently spreads to the central nervous system (CNS), but patients with CNS metastases may be excluded from clinical trials of new drugs.
Nearly half of testicular cancer risk comes from inherited genetic faults
9/10/2015
Almost half of the risk of developing testicular cancer comes from the DNA passed down from our parents, a new study reports.
Blood and teeth samples accurately predict a criminal's age
9/10/2015
Forensic biomedical scientists from KU Leuven, Belgium, have developed a test to predict individuals' age on the basis of blood or teeth samples.
Researchers find new clue to halting leukemia relapse
9/09/2015
A protein domain once considered of little importance may be key to helping patients who are fighting acute myeloid leukemia (AML) avoid a relapse.
AstraZeneca has announced updated data on AZD9291 in first-line patients with epidermal growth factor receptor mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC) and...
Afatinib benefits extend to NSCLC patients with rare mutations
9/09/2015
Afatinib shows promising clinical activity in patients with a difficult-to-treat form of non-small cell lung cancer (NSCLC), according to a new study published in The Oncologist.
Increased detection of low-risk tumors driving up thyroid cancer rates, Mayo study finds
9/09/2015
Low-risk cancers that do not have any symptoms and presumably will not cause problems in the future are responsible for the rapid increase in the number of new cases of thyroid cancer diagnosed...
Novel biodegradable implant 'captures' spreading cancer cells
9/09/2015
A tiny biodegradable implant successfully halted cancer progression in mice by 'trapping' circulating cancer cells, preventing them from starting tumors in other parts of the body.
New drug-like compounds may improve odds of men battling prostate cancer, researchers find
9/09/2015
Researchers at Southern Methodist University, Dallas, have discovered three new drug-like compounds that could ultimately offer better odds of survival to prostate cancer patients.
Precision medicine can help deliver high-quality cancer care
9/09/2015
Using genomic and precision techniques can help deliver high-quality cancer care, according to a paper published in the September issue of the US policy journal Health Affairs.